(R)-1-(3-((5-(4-(benzofuran-5-yl)phenyl)-7-oxo-4,6-diazaspiro[2.4]hept-4-en-6-yl)methyl)pyrrolidine-1-carbonyl)cyclopropanecarbonitrile

ID: ALA4130174

PubChem CID: 145960543

Max Phase: Preclinical

Molecular Formula: C29H26N4O3

Molecular Weight: 478.55

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  N#CC1(C(=O)N2CC[C@@H](CN3C(=O)C4(CC4)N=C3c3ccc(-c4ccc5occc5c4)cc3)C2)CC1

Standard InChI:  InChI=1S/C29H26N4O3/c30-18-28(9-10-28)26(34)32-13-7-19(16-32)17-33-25(31-29(11-12-29)27(33)35)21-3-1-20(2-4-21)22-5-6-24-23(15-22)8-14-36-24/h1-6,8,14-15,19H,7,9-13,16-17H2/t19-/m1/s1

Standard InChI Key:  SKEFRAXCEDZKOL-LJQANCHMSA-N

Molfile:  

     RDKit          2D

 36 42  0  0  0  0  0  0  0  0999 V2000
   36.7365  -26.9260    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.1586  -26.3482    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.9472  -27.1375    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4206  -30.2154    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.8374  -29.5056    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.0157  -29.5010    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.5625  -29.0821    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1524  -28.3699    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3319  -28.3720    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.9204  -29.0855    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.3397  -29.7944    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1589  -29.7888    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.0991  -29.0891    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6134  -28.4287    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   31.8373  -28.6846    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.6191  -29.7550    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   32.8665  -27.6463    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   33.6692  -27.4727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.2817  -28.0127    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.9875  -27.6009    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   34.8139  -26.7981    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   33.9967  -26.7166    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.3621  -26.1842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   35.1059  -25.4041    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   31.1710  -28.2016    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   36.3784  -29.0785    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7857  -29.7841    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.6008  -29.7809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7772  -28.3717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.5909  -28.3649    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.0084  -29.0671    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.8052  -28.8870    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   38.8802  -28.0735    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   38.1297  -27.7509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   36.7066  -25.7419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   37.2519  -25.1379    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  2  1  0
  1  3  1  0
  5  4  1  0
  6  5  1  0
  4  6  1  0
  7  8  2  0
  8  9  1  0
  9 10  2  0
 10 11  1  0
 11 12  2  0
 12  7  1  0
 10 13  1  0
 13 14  1  0
 14 15  1  0
 15  5  1  0
  5 16  1  0
 16 13  2  0
 14 17  1  0
 18 17  1  1
 18 19  1  0
 19 20  1  0
 20 21  1  0
 21 22  1  0
 22 18  1  0
 21 23  1  0
 23 24  2  0
 15 25  2  0
  7 26  1  0
 26 27  2  0
 27 28  1  0
 28 31  2  0
 30 29  2  0
 29 26  1  0
 30 31  1  0
 31 32  1  0
 32 33  1  0
 33 34  2  0
 34 30  1  0
 23  2  1  0
  2 35  1  0
 35 36  3  0
M  END

Alternative Forms

  1. Parent:

    ALA4130174

    ---

Associated Targets(Human)

FASN Tchem Fatty acid synthase (3390 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 478.55Molecular Weight (Monoisotopic): 478.2005AlogP: 4.37#Rotatable Bonds: 5
Polar Surface Area: 89.91Molecular Species: NEUTRALHBA: 5HBD:
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): #RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 3.24CX LogP: 3.37CX LogD: 3.37
Aromatic Rings: 3Heavy Atoms: 36QED Weighted: 0.54Np Likeness Score: -0.53

References

1. Lu T, Schubert C, Cummings MD, Bignan G, Connolly PJ, Smans K, Ludovici D, Parker MH, Meyer C, Rocaboy C, Alexander R, Grasberger B, De Breucker S, Esser N, Fraiponts E, Gilissen R, Janssens B, Peeters D, Van Nuffel L, Vermeulen P, Bischoff J, Meerpoel L..  (2018)  Design and synthesis of a series of bioavailable fatty acid synthase (FASN) KR domain inhibitors for cancer therapy.,  28  (12): [PMID:29779975] [10.1016/j.bmcl.2018.05.014]

Source